(Q39038772)

8 September 2017

title

Anti-VEGF antibody therapy induces tumor hypoxia and stanniocalcin 2 expression and potentiates growth of human colon cancer xenografts (English)

1 reference

8 September 2017

1 reference

1 reference

1 reference

10

Kyoko Kitagawa

1 reference

8 September 2017

11

Masatoshi Kitagawa

1 reference

8 September 2017

Shinichiro Miyazaki

1

1 reference

8 September 2017

Hirotoshi Kikuchi

2

1 reference

8 September 2017

Ichirota Iino

3

1 reference

8 September 2017

Takashi Uehara

4

1 reference

8 September 2017

Tomohiko Setoguchi

5

1 reference

8 September 2017

Takeshi Fujita

6

1 reference

8 September 2017

Yoshihiro Hiramatsu

7

1 reference

8 September 2017

Manabu Ohta

8

1 reference

8 September 2017

Kinji Kamiya

9

1 reference

8 September 2017

Satoshi Baba

12

1 reference

8 September 2017

Hiroyuki Konno

13

1 reference

8 September 2017

language of work or name

English

0 references

publication date

6 January 2014

1 reference

International Journal of Cancer

8 September 2017

number of pages

13

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

8 September 2017

volume

135

1 reference

8 September 2017

issue

2

1 reference

8 September 2017

page(s)

295-307

1 reference

8 September 2017

1 reference

Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?

21 January 2018

1 reference

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

VEGF-targeted therapy: mechanisms of anti-tumour activity.

21 January 2018

1 reference

Effects of novel angiogenesis inhibitors for the treatment of cancer on the cardiovascular system: focus on hypertension

21 January 2018

1 reference

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

21 January 2018

1 reference

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

21 January 2018

1 reference

Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia

21 January 2018

1 reference

Disease course patterns after discontinuation of bevacizumab: pooled analysis of randomized phase III trials

21 January 2018

1 reference

Treatment of metastatic colorectal cancer

21 January 2018

1 reference

TSU68 prevents liver metastasis of colon cancer xenografts by modulating the premetastatic niche

21 January 2018

1 reference

Oncogenic KRAS and BRAF differentially regulate hypoxia-inducible factor-1alpha and -2alpha in colon cancer

21 January 2018

1 reference

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

21 January 2018

1 reference

In vivo colocalization of 2-nitroimidazole EF5 fluorescence intensity and electron paramagnetic resonance oximetry in mouse tumors

21 January 2018

1 reference

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

21 January 2018

1 reference

Hypoxia-inducible factors and the response to hypoxic stress

21 January 2018

1 reference

Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis

21 January 2018

1 reference

Colon cancer stem cells: promise of targeted therapy.

21 January 2018

1 reference

Clinicopathological significance of stanniocalcin 2 gene expression in colorectal cancer

21 January 2018

1 reference

Stanniocalcin-2 is a HIF-1 target gene that promotes cell proliferation in hypoxia

21 January 2018

1 reference

Stanniocalcin 2 promotes invasion and is associated with metastatic stages in neuroblastoma

21 January 2018

1 reference

Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells

21 January 2018

1 reference

Rebound tumour progression after the cessation of bevacizumab therapy in patients with recurrent high-grade glioma

21 January 2018

1 reference

Modes of resistance to anti-angiogenic therapy

21 January 2018

1 reference

Evolution and roles of stanniocalcin

21 January 2018

1 reference

Mammalian stanniocalcins and cancer

21 January 2018

1 reference

Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.

21 January 2018

1 reference

Stanniocalcin 2 overexpression in castration-resistant prostate cancer and aggressive prostate cancer

21 January 2018

1 reference

Clinical significance of stanniocalcin 2 as a prognostic marker in gastric cancer

21 January 2018

1 reference

Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells

21 January 2018

1 reference

Characterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective properties

21 January 2018

1 reference

STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro.

21 January 2018

1 reference

Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics

21 January 2018

1 reference

The cancer stem cell niche(s): the crosstalk between glioma stem cells and their microenvironment

21 January 2018

1 reference

The cancer stem cell: premises, promises and challenges

21 January 2018

1 reference

Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28686

1 reference

8 September 2017

1 reference